Position in JNJ
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$3,369,166
+$868,790 QoQ
Shares Held
13,266
+29.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.54%
of 13F equity value
Holder Rank
#1,914
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Wealth Management Associates, Inc. holds $14,108,701 across 10 Drug Manufacturers - General names. JNJ ranks #1 (23.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
13,266 | $3,369,166 | |
| 2 | LLY |
ELI LILLY & Co
|
2,744 | $3,291,236 | |
| 3 | MRK |
Merck & Co., Inc.
|
15,581 | $2,002,158 | |
| 4 | ABBV |
AbbVie Inc.
|
6,759 | $1,700,834 | |
| 5 | PFE |
Pfizer Inc
|
63,133 | $1,520,242 | |
| 6 | AMGN |
Amgen Inc
|
3,099 | $1,122,209 | |
| 7 | AZN |
Astrazeneca PLC
|
1,780 | $337,523 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,535 | $320,271 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,369,166 | 13,266 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $2,500,376 | 10,229 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,131,585 | 10,300 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $1,894,065 | 10,215 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $1,523,681 | 9,975 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $1,653,258 | 9,969 | Shares | Sole | 2025-05-28 | |
| 2024-12-31 | $1,470,496 | 10,168 | Shares | Sole | 2025-05-28 | |
| 2024-09-30 | $1,651,553 | 10,191 | Shares | Sole | 2025-05-28 | |
| 2024-06-30 | $1,472,415 | 10,074 | Shares | Sole | 2025-05-28 | |
| 2024-03-31 | $1,593,606 | 10,074 | Shares | Sole | 2025-05-28 | |
| 2023-12-31 | $1,655,174 | 10,560 | Shares | Sole | 2025-05-28 | |
| 2023-09-30 | $1,678,829 | 10,779 | Shares | Sole | 2025-05-28 | |
| 2023-06-30 | $1,829,161 | 11,051 | Shares | Sole | 2025-05-28 | |
| 2023-03-31 | $1,705,000 | 11,000 | Shares | Sole | 2025-05-28 | |
| 2022-12-31 | $1,993,848 | 11,287 | Shares | Sole | 2025-05-28 | |
| 2022-09-30 | $1,625,595 | 9,951 | Shares | Sole | 2025-05-28 | |
| 2022-06-30 | $1,758,769 | 9,908 | Shares | Sole | 2025-05-28 | |
| 2022-03-31 | $1,764,324 | 9,955 | Shares | Sole | 2025-05-28 | |
| 2021-12-31 | $1,698,896 | 9,931 | Shares | Sole | 2025-05-28 | |
| 2021-09-30 | $1,552,015 | 9,610 | Shares | Sole | 2025-05-28 | |
| 2021-06-30 | $1,539,660 | 9,346 | Shares | Sole | 2025-05-28 | |
| 2021-03-31 | $1,375,445 | 8,369 | Shares | Sole | 2025-05-28 | |
| 2020-12-31 | $1,291,932 | 8,209 | Shares | Sole | 2025-05-28 | |
| 2020-09-30 | $1,216,796 | 8,173 | Shares | Sole | 2025-05-28 | |
| 2020-06-30 | $1,594,462 | 11,338 | Shares | Sole | 2025-05-28 | |
| 2020-03-31 | $1,032,386 | 7,873 | Shares | Sole | 2025-05-28 | |
| No filing history on record for this holder in this stock. | ||||||